These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8414195)

  • 1. Proline-directed kinase systems in Alzheimer's disease pathology.
    Wood JG; Lu Q; Reich C; Zinsmeister P
    Neurosci Lett; 1993 Jun; 156(1-2):83-6. PubMed ID: 8414195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease.
    Hyman BT; Elvhage TE; Reiter J
    Am J Pathol; 1994 Mar; 144(3):565-72. PubMed ID: 8129042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation.
    Baum L; Hansen L; Masliah E; Saitoh T
    Mol Chem Neuropathol; 1996; 29(2-3):253-61. PubMed ID: 8971700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S6 kinase phosphorylated at T229 is involved in tau and actin pathologies in Alzheimer's disease.
    Sonoda Y; Tooyama I; Mukai H; Maeda K; Akiyama H; Kawamata T
    Neuropathology; 2016 Aug; 36(4):325-32. PubMed ID: 26582459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
    Vincent I; Jicha G; Rosado M; Dickson DW
    J Neurosci; 1997 May; 17(10):3588-98. PubMed ID: 9133382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration.
    Pei JJ; Braak H; Gong CX; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
    Acta Neuropathol; 2002 Oct; 104(4):369-76. PubMed ID: 12200623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of protein phosphatases (PP-1, PP-2A, PP-2B and PTP-1B) and protein kinases (MAP kinase and P34cdc2) in the hippocampus of patients with Alzheimer disease and normal aged individuals.
    Pei JJ; Sersen E; Iqbal K; Grundke-Iqbal I
    Brain Res; 1994 Aug; 655(1-2):70-6. PubMed ID: 7812792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
    Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
    Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.
    Zhu X; Raina AK; Rottkamp CA; Aliev G; Perry G; Boux H; Smith MA
    J Neurochem; 2001 Jan; 76(2):435-41. PubMed ID: 11208906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments.
    Liu WK; Williams RT; Hall FL; Dickson DW; Yen SH
    Am J Pathol; 1995 Jan; 146(1):228-38. PubMed ID: 7856730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology.
    Dranovsky A; Vincent I; Gregori L; Schwarzman A; Colflesh D; Enghild J; Strittmatter W; Davies P; Goldgaber D
    Neurobiol Aging; 2001; 22(4):517-28. PubMed ID: 11445251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
    Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
    Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal neurons predisposed to neurofibrillary tangle formation are enriched in type II calcium/calmodulin-dependent protein kinase.
    McKee AC; Kosik KS; Kennedy MB; Kowall NW
    J Neuropathol Exp Neurol; 1990 Jan; 49(1):49-63. PubMed ID: 2153760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p44mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons.
    Lu Q; Soria JP; Wood JG
    J Neurosci Res; 1993 Jul; 35(4):439-44. PubMed ID: 7689658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcineurin (phosphatase 2B) is present in neurons containing neurofibrillary tangles and in a subset of senile plaques in Alzheimer's disease.
    Brion JP; Couck AM; Conreur JL
    Neurodegeneration; 1995 Mar; 4(1):13-21. PubMed ID: 7600182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathology of the neuronal cytoskeleton in Alzheimer's disease.
    Brion JP
    Biochim Biophys Acta; 1992 Nov; 1160(1):134-42. PubMed ID: 1384716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain.
    Lee KY; Clark AW; Rosales JL; Chapman K; Fung T; Johnston RN
    Neurosci Res; 1999 May; 34(1):21-9. PubMed ID: 10413323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins.
    Layfield R; Fergusson J; Aitken A; Lowe J; Landon M; Mayer RJ
    Neurosci Lett; 1996 May; 209(1):57-60. PubMed ID: 8734909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topographic regulation of kinase activity in Alzheimer's disease brains.
    Grant P; Pant HC
    J Alzheimers Dis; 2002 Aug; 4(4):269-81. PubMed ID: 12446929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of the mitogen activated protein kinase ERK2 in Alzheimer's disease neurofibrillary tangles and senile plaque neurites.
    Trojanowski JQ; Mawal-Dewan M; Schmidt ML; Martin J; Lee VM
    Brain Res; 1993 Aug; 618(2):333-7. PubMed ID: 8374766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.